In contrast, chemical-induced colitis increases the percentage of CB1R-expressing myenteric neurons, while the cannabinoid receptor agonist HU210 or the genetic ablation of FAAH protects from the chemical-induced colitis (Massa et al., 2004). This evidence concerns the gene CNR1 and colitis.